316 related articles for article (PubMed ID: 9850055)
41. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
42. Methylation of the 5' CpG island of the endothelin B receptor gene is common in human prostate cancer.
Nelson JB; Lee WH; Nguyen SH; Jarrard DF; Brooks JD; Magnuson SR; Opgenorth TJ; Nelson WG; Bova GS
Cancer Res; 1997 Jan; 57(1):35-7. PubMed ID: 8988036
[TBL] [Abstract][Full Text] [Related]
43. Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer.
Kang HY; Huang HY; Hsieh CY; Li CF; Shyr CR; Tsai MY; Chang C; Chuang YC; Huang KE
J Bone Miner Res; 2009 Jul; 24(7):1180-93. PubMed ID: 19257827
[TBL] [Abstract][Full Text] [Related]
44. [Differential regulation of androgen receptor promoter in hormone-sensitive and -insensitive prostate carcinoma cells].
Kopp H; Masters JR; Wieland W; Hofstaedter F; Buettner R
Verh Dtsch Ges Pathol; 1993; 77():129-32. PubMed ID: 7511270
[TBL] [Abstract][Full Text] [Related]
45. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.
Sasaki M; Tanaka Y; Perinchery G; Dharia A; Kotcherguina I; Fujimoto Si; Dahiya R
J Natl Cancer Inst; 2002 Mar; 94(5):384-90. PubMed ID: 11880477
[TBL] [Abstract][Full Text] [Related]
46. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
[TBL] [Abstract][Full Text] [Related]
47. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff JR; Herman JG; Lapidus RG; Chopra H; Xu R; Jarrard DF; Isaacs WB; Pitha PM; Davidson NE; Baylin SB
Cancer Res; 1995 Nov; 55(22):5195-9. PubMed ID: 7585573
[TBL] [Abstract][Full Text] [Related]
48. Androgen receptor CpG island methylation status in human leukemia cancer cells.
Liu ZJ; Wang G; Cai Y; Gu SZ; Zhang XB; Liu L; Gao X
Cancer Invest; 2009 Feb; 27(2):156-62. PubMed ID: 19235587
[TBL] [Abstract][Full Text] [Related]
49. Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene.
Schayek H; Bentov I; Sun S; Plymate SR; Werner H
Exp Cell Res; 2010 May; 316(9):1479-88. PubMed ID: 20338164
[TBL] [Abstract][Full Text] [Related]
50. Expression of the human Sd(a) beta-1,4-N-acetylgalactosaminyltransferase II gene is dependent on the promoter methylation status.
Wang HR; Hsieh CY; Twu YC; Yu LC
Glycobiology; 2008 Jan; 18(1):104-13. PubMed ID: 17965433
[TBL] [Abstract][Full Text] [Related]
51. P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer.
Jarrard DF; Paul R; van Bokhoven A; Nguyen SH; Bova GS; Wheelock MJ; Johnson KR; Schalken J; Bussemakers M; Isaacs WB
Clin Cancer Res; 1997 Nov; 3(11):2121-8. PubMed ID: 9815605
[TBL] [Abstract][Full Text] [Related]
52. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
[TBL] [Abstract][Full Text] [Related]
53. Mapping of ER gene CpG island methylation-specific polymerase chain reaction.
Lapidus RG; Nass SJ; Butash KA; Parl FF; Weitzman SA; Graff JG; Herman JG; Davidson NE
Cancer Res; 1998 Jun; 58(12):2515-9. PubMed ID: 9635570
[TBL] [Abstract][Full Text] [Related]
54. Androgen regulated TRPM8 expression: a potential mRNA marker for metastatic prostate cancer detection in body fluids.
Bai VU; Murthy S; Chinnakannu K; Muhletaler F; Tejwani S; Barrack ER; Kim SH; Menon M; Veer Reddy GP
Int J Oncol; 2010 Feb; 36(2):443-50. PubMed ID: 20043080
[TBL] [Abstract][Full Text] [Related]
55. Androgen receptor gene expression in human prostate carcinoma cell lines.
Tilley WD; Wilson CM; Marcelli M; McPhaul MJ
Cancer Res; 1990 Sep; 50(17):5382-6. PubMed ID: 2386943
[TBL] [Abstract][Full Text] [Related]
56. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
57. Paired box 2 upregulates androgen receptor gene expression in androgen-independent prostate cancer.
Ito S; Ueda T; Ueno A; Nakagawa H; Taniguchi H; Hongo F; Kamoi K; Okihara K; Kawauchi A; Miki T
FEBS J; 2014 Oct; 281(19):4506-18. PubMed ID: 25132193
[TBL] [Abstract][Full Text] [Related]
58. Retention of unmethylated CpG island alleles in human diploid fibroblast x fibrosarcoma hybrids expressing high levels of DNA methyltransferase.
Kuerbitz SJ; Baylin SB
Cell Growth Differ; 1996 Jun; 7(6):847-53. PubMed ID: 8780898
[TBL] [Abstract][Full Text] [Related]
59. Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth.
Wolff DW; Xie Y; Deng C; Gatalica Z; Yang M; Wang B; Wang J; Lin MF; Abel PW; Tu Y
Int J Cancer; 2012 Apr; 130(7):1521-31. PubMed ID: 21500190
[TBL] [Abstract][Full Text] [Related]
60. Defining a functional androgen responsive element in the 5' far upstream flanking region of the prostate-specific antigen gene.
Zhang S; Murtha PE; Young CY
Biochem Biophys Res Commun; 1997 Feb; 231(3):784-8. PubMed ID: 9070893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
